MedPath
HSA Approval

SODIUM CHLORIDE PARENTERAL SOLUTION 0.9%

SIN10312P

SODIUM CHLORIDE PARENTERAL SOLUTION 0.9%

SODIUM CHLORIDE PARENTERAL SOLUTION 0.9%

October 29, 1998

JOYSON PTE. LTD.

JOYSON PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJOYSON PTE. LTD.
Licence HolderJOYSON PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA03

sodium chloride

Manufacturer Information

JOYSON PTE. LTD.

EURO-MED LABORATORIES PHIL INC

Active Ingredients

SODIUM CHLORIDE

900 mg/100 ml

Sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM CHLORIDE PARENTERAL SOLUTION 0.9% - HSA Approval | MedPath